✦ LIBER ✦

Cisplatin (CDDP), epirubicin (EDX) and vindesine (VDS) +/− lonidamina (LND) in advanced NSCLC

✍ Scribed by Ianniello, G.P.; De Cataldis, G.; Della Vittoria Scarpati, G.; Comella, P.; Maiorino, A.; Brancaccio, L.; Belli, M.; Cioffi, R.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of ifosfamide (IFX), cisp

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Randomized study comparing cisplatin(CDD

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 126 KB

Cisplatin (CDDP) and irinotecan (CPT-11)

✍ H. Kunitoh; N. Saijo; K. Nagao; Y. Ohashi; H. Niitani 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 350 KB

The final results of a randomized phase

✍ Takiguchi, Y; Nagao, K; Nishiwaki, Y; Yokoyama, A; Saijo, N; Ohashi, Y; Niitani, 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 219 KB

High-dose epirubicin(HD-EPI) plus cispla

✍ Galvez, C.A. 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 140 KB

39 Six year follow up of the European Mu

✍ Le Chevalier, T.; Pujol, J.L.; Douilard, J.Y.; Alberola, V.; Monnier, A.; Rivièr 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 144 KB